[A NEW OSMOTIC DRUG: HYPERTONIC SOLUTION OF MANNITOL. ADVANTAGES AS COMPARED WITH UREA. USE IN THE TREATMENT OF ASEPTIC SEROUS MENINGITIS AND POSTOPERATIVE CEREBROSPINAL FLUID FISTULAS].
D001932:Brain Neoplasms; D002528:Cerebellar Neoplasms; D003056:Cochlear Nerve; D004806:Ependymoma; D005402:Fistula; D005910:Glioma; D006982:Hypertonic Solutions; D007427:Intracranial Pressure; D008353:Mannitol; D008527:Medulloblastoma; D008577:Meningeal Neoplasms; D008579:Meningioma; D008581:Meningitis; D009442:Neurilemmoma; D009493:Neurosurgery; D011183:Postoperative Complications; D014508:Urea
D006982:Hypertonic Solutions; D008353:Mannitol; D014508:Urea
ACOUSTIC NERVE; BRAIN NEOPLASMS; EPENDYMOMA; GLIOMA; HYPERTONIC SOLUTIONS; INTRACRANIAL PRESSURE; MANNITOL; MEDULLOBLASTOMA; MENINGIOMA; MENINGITIS; NEURILEMMOMA; NEUROSURGERY; POSTOPERATIVE COMPLICATIONS
UN NUOVO FARMACO OSMOTICO: SOLUZIONE IPERTONICA DI MANNITOLO. VANTAGGI NEI CONFRONTI  DELL'UREA. IMPIEGO NEL TRATTAMENTO DELLE MENINGITI SIEROSE ASETTICHE E DELLE FISTOLE LIQUORALI POST-OPERATORIE.